Speakers, Kathleen Wyne, MD, PhD, FACE, FNLA, George Grunberger, MD, FACP, FACE, and Felice Caldarella, MD, FACP, CDE, FACE, discuss the significant improvements in accuracy of Continuous Glucose Monitor (CGM) sensors and device algorithms that have made CGM-based treatment decisions a current reality. The program also evaluates the clinical application of CGM in diabetes management decisions and the importance of various aspects of CGM to guide optimal treatment, regardless of insulin mode of administration.
Thursday, May 17, 2018, 5:15am- 7:30am
Sheraton Boston Hotel, Constitution Ballroom A-B, Level 2
39 Dalton St, Boston, Massachusetts
Dexcom is pleased to sponsor a quarterly podcast series to complement Diabetes Technology & Therapeutics. The podcast series features prominent medical doctors and certified diabetes educators discussing continuos glucose monitoring (CGM),...